Release Date: 09/12/22 09:52 Summary: $60m capital raise to accelerate development and exploration Price Sensitive: Yes Download Document 472.65KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%